| |
| Magyar Belgyógyász Társaság |
|
| Magyar Belgyógyász Társaság 45. Nagygyűlés (Budapest, 2014.11.27-29.) |
 Rendezvény kezdete: 2014.11.27. | Rendezvény vége: 2014.11.29. |
| Helyszín: Budapest, Rákóczi út 43-45., Novotel Budapest Centrum |
| A rendezvény Web oldala: http://mbtngy.felabor.hu |
Időpont: 2014. november 27-29.
Helyszín: Novotel Budapest Centrum (Régi Hotel Palace), Budapest Rákóczi út 43-45. (Rákóczi út Nagykörút kereszteződéstől 2 perc gyalog)
Megközelíthető: Metro 2 (piros) vonal Blaha Lujza tér megálló, autóbusz 7-es, 73-as, 173-as, villamos: 4-es és 6-os , gépkocsival – Rákóczi útról 20 méterre, a Csokonay utcára nyíló 8 emeletes, 200 férőhelyes parkoló garázs áll rendelkezésre szállodai átjáróval)
Jelentkezés: elektronikus úton, http://mbtngy.felabor.hu honlapon lehetséges, vagy az alább letölthető jelentkezési lapon, postán.
Technikai szervező: Felabor Hungary Kft, Dr. Szalay Ferenc
Tel: 215-1224 vagy Tel/Fax: 210-1007
E-mail: felabor.hungary@gmail.com vagy szalay.ferenc@med.semmelweis-univ.hu
Őszintén reméljük, hogy a Magyar Belgyógyász Társaság 45. Nagygyűlésének programja elnyeri tetszését és aktívan részt vesz kongresszusunkon előadóként és hallgatóként egyaránt.
A program és az előadáskivonatok letölthetőek ide kattintva >>
A jelentkezési lap letölthető ide kattintva >> |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
